Patient characteristics
| Patient | Age at clinical onset of SLE (years) | Age at onset of optic neuritis (years) | Initial VA | Length of follow up (months) | Final VA | Treatment | Other SLE features | ||||||
| FS | 42 | 53 | RE: NLP | 24 | RE: 20/25 | Cyclophosphamide iv, prednisone orally, methylprednisolone iv | Arthritis, nephritis, pleuritis, alopecia, possible pneumonitis | ||||||
| LE: LP | LE: 20/30 | ||||||||||||
| YJ | 25 | 32 | RE:20/20 | 50 | RE: 20/25 | Cyclophosphamide iv × 2 | Myelopathy, peripheral neuropathy, seizures, pleuropericarditis, arthritis | ||||||
| LE: HM | LE: 20/20 | ||||||||||||
| FB | 53 | 56 | RE: LP | 69 | RE: 20/30 | Cyclophosphamide iv × 2, prednisone orally | Seizures, mononeuritis multiplex, polyarthritis, proteinuria/casts | ||||||
| LE: 20/20 | LE: 20/20 | ||||||||||||
RE = right eye; LE = left eye; NLP = no light perception; LP = light perception; HM = hand movements.